EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tranexamic acid reduces blood loss and transfusion in single-stage bilateral combined surgery for developmental dysplasia of the hip: A retrospective study

Shiwei Li iD, Xueyang Tang iD, Xiaodong Yang iD

Journal of Children's Orthopaedics · 2026-06 · 20 (3) · 241-246

DOI: 10.1177/18632521261429003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Children's Orthopaedics, online erschienen am 20.03.2026. Verfasst von Shiwei Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinical Research Incubation Project of West China Hospital of Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine whether tranexamic acid (TXA) reduces blood loss and transfusion rate in single-stage bilateral combined surgery for developmental dysplasia of the hip (DDH) in children.

Methods

A retrospective study was conducted on 148 children with bilateral DDH who underwent single-stage bilateral combined surgery between March 2021 and May 2025. Patients were categorized into a TXA group ( n = 71) and a control group ( n = 77) based on TXA administration. The TXA group received a single intravenous bolus of TXA 15 mg/kg preoperatively, while the control group received no intervention. Complete blood count tests were obtained preoperatively and at 24 h postoperatively. Estimated blood loss (EBL), transfusion rate, operative duration, and complications were compared.

Results

The TXA group exhibited significantly lower EBL compared with the control group (117.5 ± 7.7 mL vs. 171.4 ± 11.3 mL; p < 0.001). The total transfusion rate was also lower in the TXA group (5.6 % vs. 16.9 %; p = 0.03), as well as the intraoperative transfusion rate (1.4% vs. 11.7%; p = 0.03). The median surgical duration was 2.3 h in both groups, with no significant difference ( p = 0.29). One postoperative infection occurred in each group (1.4 % vs. 1.3 %; p = 1), and no cases of seizures or deep vein thrombosis were observed.

Conclusions

TXA significantly reduces EBL and both total and intraoperative transfusion rates in children undergoing single-stage bilateral combined surgery for DDH, without affecting the risk of complications.

Schlagwörter

Stichwörter der Autor:innen

Tranexamic aciddevelopmental dysplasia of the hiphemostasisinnominate osteotomypediatric orthopedics

Autor:innen und Institutionen

  • Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Shiwei Li, Xueyang Tang, Xiaodong Yang

Förderung

  • Clinical Research Incubation Project of West China Hospital of Sichuan University

Zitieren

APA

Li, S., Tang, X., & Yang, X. (2026). Tranexamic acid reduces blood loss and transfusion in single-stage bilateral combined surgery for developmental dysplasia of the hip: A retrospective study. Journal of Children's Orthopaedics, 20(3), 241-246. https://doi.org/10.1177/18632521261429003

Vancouver

Li S, Tang X, Yang X. Tranexamic acid reduces blood loss and transfusion in single-stage bilateral combined surgery for developmental dysplasia of the hip: A retrospective study. Journal of Children's Orthopaedics. 2026;20(3):241-246. doi:10.1177/18632521261429003

BibTeX
@article{Li2026,
  author = {Li, Shiwei and Tang, Xueyang and Yang, Xiaodong},
  title = {Tranexamic acid reduces blood loss and transfusion in single-stage bilateral combined surgery for developmental dysplasia of the hip: A retrospective study},
  journal = {Journal of Children's Orthopaedics},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {241--246},
  doi = {10.1177/18632521261429003}
}
Kostenlos starten →